SC-116

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameSC-116

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionOsteogenesis stimulants

TargetsUpdating

Therapy Area/IndicationsOsteoporosis, Postmenopausal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesScotia

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesScotia

Active IndicationsN/A

Inactive IndicationsOsteoporosis, Postmenopausal

ATC CodeN/A